News search

This new tool will advance the development of treatments for congenital muscle diseases and cardiomyopathies. 

Dr. Jonathan Kipnis is a Principal Investigator and the Alan A. and Edith L. Wolff Distinguished Professor of Pathology and Immunology at Washington University

A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the Instituto de Investigación Biomédica de Barcelona (IRB Barcelona), has identified the most effective subtype of dendritic cell for generating immune memory in response to cancer

The discovery, published in Nature, opens the path to new strategies for treating skin diseases and immunological disorders, with special potential for the treatment of inflammation, diabetes, and age-related conditions

The study describes an innovative probe for the noninvasive detection of macrophages using PET technology

iFlpMosaics is a new technology presented in Nature Methods that allows the modification and study of gene function in mouse models, advancing research on diseases caused by somatic mutations, such as cancer and vascular malformations.

A study from the CNIC, published in Nature Communications, reveals how caveolae allow adipocytes to expand safely, storing fat without breaking or causing inflammation

Two studies carried out at the CNIC provide key information about a newly identified cardiovascular risk factor, clonal hematopoiesis, and its treatment with the ancient medication colchicine